Theodore B Moore

Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency

Barbara Engel, John Tse, David Gjertson, 2017, The Journal of clinical investigation.

Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia.

S. Bhatia, G. Sandusky, K. Sakamoto, 2002, Blood.

ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia.

Yujia Dai, K. Glaser, S. Davidsen, 2007, Blood.

RNA interference and human disease.

K. Sakamoto, Jerry Cheng, T. Moore, 2003, Molecular genetics and metabolism.

FMS‐Like Tyrosine Kinase 3 in Normal Hematopoiesis and Acute Myeloid Leukemia

K. Sakamoto, T. Moore, Theodore B Moore, 2006, Stem cells.